Back to Peptides
CognitiveLow Risk

Pinealon

Also known as: Cortagen, EDR tripeptide

Half-life:
Unknown

Administration Routes

intranasalsubcutaneous injection
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Glu-Asp-Arg tripeptide; penetrates blood-brain barrier; modulates gene expression in neurons; reduces oxidative stress in brain tissue

A short synthetic peptide targeting brain tissue with neuroprotective and antioxidant properties. Part of the Khavinson peptide bioregulator family.

Primary Research Areas

  • neuroprotection
  • antioxidant (CNS)
  • sleep improvement
  • anti-aging (brain)

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Russian peptide bioregulator (Glu-Asp-Arg) from pineal gland, Khavinson Institute. Studied for visual function and longevity. No FDA approval, no NDA or IND. Research chemical in US.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find Pinealon

No active associated providers listed yet.